Sandra E. Black
500 University Ave
Toronto, ON, Canada
Toronto, ON, Canada
Last Updated: 09/26/2026
Save publications for later
Sign Up
Not sure about your diagnosis?
Check Your Symptoms
Found 457 publications
Age at menopause, APOE-ε4, and Alzheimer's disease risk.
Journal: Research square
Published: August 01, 2026
Age at menopause, APOE-ε4, and Alzheimer's disease risk.
Journal: Research square
Published: August 01, 2026
Substantia Innominata : Atrophy, Gait Variability and Dual-Task Gait Across the Lewy Body Disease Spectrum.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: May 21, 2026
Substantia Innominata: Atrophy, Gait Variability and Dual task Gait Across the Lewy Body Disease Spectrum.
Journal: The Canadian journal of neurological sciences. Le journal canadien des sciences neurologiques
Published: May 21, 2026
Blood-based biomarkers for Alzheimer's disease. 'Treat the test, not the patient?'; are we ready to defy Osler?
Journal: Expert review of molecular diagnostics
Published: May 10, 2026
Examining the effects of alcohol use on verbal memory processes in older adults with mild cognitive impairment.
Journal: Journal of Alzheimer's disease : JAD
Published: April 25, 2026
Apoptosis protein markers in comorbid type 2 diabetes mellitus and depression; relationships with cognitive performance, incident dementia, and white matter hyperintensities.
Journal: Journal of affective disorders
Published: March 23, 2026
Publisher Correction: Anticoagulation to prevent ischemic stroke and neurocognitive impairment in atrial fibrillation: the BRAIN-AF randomized clinical trial.
Journal: Nature medicine
Published: February 04, 2026
Serum long-chain omega-3 and omega-6 fatty acids differentially predict brain atrophy, white matter hyperintensities, and lacunes in individuals with cerebral small vessel disease with or without Alzheimer's disease.
Journal: Journal of Alzheimer's disease : JAD
Published: December 24, 2025
Identifying a combination of biomarkers to predict treatment response to nabilone for agitation in Alzheimer's disease - an exploratory post hoc analysis.
Journal: Neurodegenerative disease management
Published: November 12, 2025
Cardiovascular risk factors and vascular neuropathological findings in primary age-related tauopathy versus Alzheimer's disease.
Journal: GeroScience
Published: October 24, 2025
Efficacy and safety of N-acetylcysteine in patients with mild cognitive impairment undergoing exercise-based cardiac rehabilitation program: a randomized controlled trial.
Journal: Alzheimer's research & therapy
Published: October 17, 2025
Last Updated: 09/26/2026